INSP Earnings Prediction
The chart below shows how INSP performed 10 days before and after its earnings report, based on data from the past quarters. Typically, INSP sees a -0.92% change in stock price 10 days leading up to the earnings, and a -3.86% change 10 days following the report. On the earnings day itself, the stock moves by +0.24%. This data can give you a slight idea of what to expect for the next quarter's release.
INSP Key Earning Data
2024/Q4
Year Over Year
Quarter Over Quarter
Total Revenue
239.72M
24.52%
17.98%
Gross Margin
84.99%
-0.52%
1.11%
Operating Margin
13.30%
175.36%
88.65%
Net Margin
14.69%
91.53%
61.43%
EPS
1.16
132.00%
93.33%
No Data Available
INSP Earnings Analysis
Inspire Medical Systems Inc Corporation (INSP.N) Earnings Conference Call
Positive
Earnings Surprise Performance: Inspire Medical Systems reported a Q4 2024 EPS of $1.15, significantly exceeding expectations of $0.74, marking a strong performance in earnings.
Q4 Revenue Surge: Total revenue for Q4 2024 reached $239.7 million, a 25% increase from $192.5 million in Q4 2023, demonstrating robust growth.
Annual Revenue Increase: For the full year 2024, revenue totaled $802.8 million, reflecting a 28% increase over $624.8 million in 2023, indicating strong annual growth.
Net Income Turnaround: Net income for the full year 2024 was $53.5 million, compared to a net loss of $21.2 million in 2023, showcasing a significant turnaround to profitability.
Operating Cash Flow Increase: The company generated $130 million in operating cash flow for the full year 2024, enhancing its cash position to $517 million, which supports future growth initiatives.
Negative
Operating Expenses Increase: Total operating expenses for the quarter were $171.8 million, an increase of 11% compared to $155.2 million in the fourth quarter of 2023, indicating rising costs that could impact future profitability.
Interest and Dividend Income Decline: Interest and dividend income totaled $5.5 million in the quarter, a decrease from $5.9 million in the prior year period, reflecting a decline in income from investments.
International Revenue Insights: Revenue outside the U.S. was $8.1 million, which, despite a 163% increase year-over-year, remains a small fraction of total revenue, highlighting reliance on the U.S. market.
Legal Risks and Investigations: The company received a civil investigative demand from the Department of Justice regarding marketing and reimbursement practices, introducing potential legal risks and uncertainties.
Net Income Margin Analysis: Despite achieving profitability in 2024, the net income margin was only 7%, compared to a net loss margin of 3% in 2023, indicating that while the company is profitable, margins remain thin.
INSP FAQs
How does INSP typically perform around its earnings report dates?
Is Inspire Medical Systems Inc (INSP) Q4 2024 Earnings Call Summary positive or negative?
How can historical earnings data help predict future stock performance?
INSP Earning Call Sentiment
Inspire Medical Systems, Inc. (NYSE:INSP) Q4 2024 Earnings Call Transcript
INSP.N
-0.6%Positive
The earnings call reflects strong financial performance with a 28% revenue growth and improved margins, along with optimistic guidance for 2024 and 2025. While the Q&A section raised some concerns, such as the DOJ investigation and vague responses, overall sentiment remains positive due to increased revenue guidance, improved profitability, and strategic market expansion. The market cap suggests moderate volatility, leading to a predicted positive stock price movement (2% to 8%) over the next two weeks.
